PT869945E - Derivados dos dieteres de catecol uteis como agentes farmaceuticos - Google Patents

Derivados dos dieteres de catecol uteis como agentes farmaceuticos

Info

Publication number
PT869945E
PT869945E PT95923739T PT95923739T PT869945E PT 869945 E PT869945 E PT 869945E PT 95923739 T PT95923739 T PT 95923739T PT 95923739 T PT95923739 T PT 95923739T PT 869945 E PT869945 E PT 869945E
Authority
PT
Portugal
Prior art keywords
pct
ueth
catech
dieters
derivatives
Prior art date
Application number
PT95923739T
Other languages
English (en)
Inventor
Allen J Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT869945E publication Critical patent/PT869945E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Pyridine Compounds (AREA)
PT95923739T 1995-06-07 1995-06-07 Derivados dos dieteres de catecol uteis como agentes farmaceuticos PT869945E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007208 WO1996040636A1 (en) 1995-06-07 1995-06-07 Catechol diethers derivatives useful as pharmaceutical agents

Publications (1)

Publication Number Publication Date
PT869945E true PT869945E (pt) 2003-09-30

Family

ID=22249266

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95923739T PT869945E (pt) 1995-06-07 1995-06-07 Derivados dos dieteres de catecol uteis como agentes farmaceuticos

Country Status (11)

Country Link
US (1) US6028086A (pt)
EP (1) EP0869945B1 (pt)
JP (1) JP3410104B2 (pt)
AT (1) ATE237589T1 (pt)
CA (1) CA2223245C (pt)
DE (1) DE69530429T2 (pt)
DK (1) DK0869945T3 (pt)
ES (1) ES2193196T3 (pt)
FI (1) FI114468B (pt)
PT (1) PT869945E (pt)
WO (1) WO1996040636A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9903919D0 (en) * 1999-02-19 1999-04-14 Darwin Discovery Ltd Aminophenols and their therapeutic use
EA006685B1 (ru) 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
EP2258689A1 (en) * 2000-03-16 2010-12-08 Biolipox AB Benzylated PDE4 inhibitors
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
EP1559716B1 (en) 2002-11-06 2011-09-14 ASKA Pharmaceutical Co., Ltd. Pyrazolonaphthyridine derivative
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
KR20080046728A (ko) 2005-09-15 2008-05-27 아스카 세이야쿠 가부시키가이샤 복소환 화합물, 그의 제조 방법 및 용도
CA2858520A1 (en) * 2006-05-18 2007-11-29 Pharmacyclics Inc. Intracellular kinase inhibitors
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
GB9315595D0 (en) * 1993-07-28 1993-09-08 Res Inst Medicine Chem New compounds

Also Published As

Publication number Publication date
DK0869945T3 (da) 2003-07-14
DE69530429D1 (de) 2003-05-22
CA2223245A1 (en) 1996-12-19
EP0869945B1 (en) 2003-04-16
US6028086A (en) 2000-02-22
FI974442A0 (fi) 1997-12-05
JP3410104B2 (ja) 2003-05-26
ATE237589T1 (de) 2003-05-15
WO1996040636A1 (en) 1996-12-19
CA2223245C (en) 2002-05-21
FI974442A (fi) 1997-12-05
JP2001527508A (ja) 2001-12-25
EP0869945A1 (en) 1998-10-14
FI114468B (fi) 2004-10-29
ES2193196T3 (es) 2003-11-01
MX9709869A (es) 1998-03-31
DE69530429T2 (de) 2003-10-30

Similar Documents

Publication Publication Date Title
NO971811L (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
CA2166721A1 (en) Bicyclic tetrahydro pyrazolopyridines
ATE165830T1 (de) Dihydro pyrazolopyrrole
FI945555A0 (fi) Substituoituja oksindoleja
US5236927A (en) Anti-cancer quinazoline derivatives
PT869945E (pt) Derivados dos dieteres de catecol uteis como agentes farmaceuticos
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
ATE284860T1 (de) Neue verwendung von phenylheteroalkylamin- derivaten
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
ATE197038T1 (de) N-aroyl-glycin-hydroxamsäure-derivate und verwandte verbindungen
DE69332762T2 (de) Cathecoldiether als selektive pde iv hemmungsmittel
JP2006503048A5 (pt)
EA200200662A1 (ru) Никотинамидные бензоконденсированные гетероциклические производные, полезные в качестве селективных ингибиторов pde4-изозимов
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
MY116527A (en) Tricyclic 5, 6-dihydro-9h-pyrazolo [3,4,-c]-1,2,4- triazolo [4,3-a] pyridines
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
WO2001018004A2 (de) PYRAZOLO[4,3-d]PYRIMIDINE
BR0010693A (pt) Derivados azaindol para tratamento de depressão
ATE389655T1 (de) Pyrimidinderivate
AU2016381152B2 (en) Indolizine derivatives, composition and methods of use
ATE265428T1 (de) Neue verwendung von phenylheteroalkylamin- derivaten
KR920018025A (ko) 퀴논 유도체
ZA200102187B (en) Chemical compounds.